Citigroup Inc Avidity Biosciences, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Citigroup Inc holds 111,682 shares of RNA stock, worth $4.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

111,682

Previous 43,921 154.28%

Holding current value

$4.87 Million

Previous $1.79 Million 185.9%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$37.21 - $48.14 $2.52 Million - $3.26 Million	67,761 Added 154.28%	111,682 $5.13 Million
Q2 2024 Aug 12, 2024	SELL	$22.73 - $40.85 $4.36 Million - $7.84 Million	-191,944 Reduced 81.38%	43,921 $1.79 Million
Q1 2024 May 10, 2024	BUY	$9.16 - $25.52 $1.38 Million - $3.83 Million	150,263 Added 175.54%	235,865 $6.02 Million
Q4 2023 Feb 09, 2024	SELL	$4.87 - $9.37 $277,229 - $533,396	-56,926 Reduced 39.94%	85,602 $774,000
Q3 2023 Nov 09, 2023	SELL	$6.3 - $11.35 $228,085 - $410,915	-36,204 Reduced 20.26%	142,528 $909,000
Q2 2023 Aug 10, 2023	SELL	$10.62 - $17.34 $805,410 - $1.32 Million	-75,839 Reduced 29.79%	178,732 $1.98 Million
Q1 2023 May 11, 2023	BUY	$15.35 - $25.65 $2.14 Million - $3.58 Million	139,726 Added 121.66%	254,571 $3.91 Million
Q4 2022 Feb 09, 2023	BUY	$10.06 - $22.66 $469,641 - $1.06 Million	46,684 Added 68.49%	114,845 $2.55 Million
Q3 2022 Nov 10, 2022	BUY	$15.46 - $23.43 $184,221 - $279,191	11,916 Added 21.19%	68,161 $1.11 Million
Q2 2022 Aug 10, 2022	BUY	$11.18 - $20.5 $319,557 - $585,951	28,583 Added 103.33%	56,245 $817,000
Q1 2022 May 12, 2022	SELL	$14.2 - $23.78 $654,321 - $1.1 Million	-46,079 Reduced 62.49%	27,662 $511,000
Q4 2021 Feb 10, 2022	BUY	$20.4 - $28.66 $297,758 - $418,321	14,596 Added 24.68%	73,741 $1.75 Million
Q3 2021 Nov 10, 2021	BUY	$18.16 - $25.21 $1.07 Million - $1.49 Million	59,145 New	59,145 $1.46 Million

Others Institutions Holding RNA

# of Institutions

256

Shares Held

107M

Call Options Held

224K

Put Options Held

161K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.28B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account